The effect of acute tryptophan depletion on mood and impulsivity in polydrug ecstasy users
- PMID: 24142202
- DOI: 10.1007/s00213-013-3287-2
The effect of acute tryptophan depletion on mood and impulsivity in polydrug ecstasy users
Abstract
Rationale: Several studies suggest users of 3,4-methylenedioxymethamphetamine (ecstasy) have low levels of serotonin. Low serotonin may make them susceptible to lowered mood.
Objective: This work aims to study the acute effects on mood and impulsivity of lowering serotonin levels with acute tryptophan depletion in polydrug ecstasy users and to determine whether effects were different in men and women.
Methods: In a double-blind cross-over study, participants who had used ecstasy at least 25 times (n = 13) and nonuser controls (n = 17) received a tryptophan-deficient amino acid mixture and a control amino acid mixture containing tryptophan, at least 1 week apart. Mood was measured using the profile of mood states, and impulsivity was measured with the Go/No-Go task.
Results: The main result shows that a lowering of mood after acute tryptophan depletion occurred only in female polydrug ecstasy users (n = 7), relative to controls (n = 9). Results from the Go/No-Go task suggested that impulsivity was not increased by acute tryptophan depletion in polydrug ecstasy users.
Limitation: The group sizes were small, when males and females were considered separately.
Conclusions: Women polydrug ecstasy users appear to be more susceptible than men to the effects of lowered serotonin levels. If use of ecstasy alone or in conjunction with other drugs causes progressive damage of serotonin neurons, women polydrug ecstasy users may become susceptible to clinical depression.
Similar articles
-
Altered response to tryptophan supplementation after long-term abstention from MDMA (ecstasy) is highly correlated with human memory function.Psychopharmacology (Berl). 2003 Aug;169(1):91-103. doi: 10.1007/s00213-003-1463-5. Epub 2003 May 21. Psychopharmacology (Berl). 2003. PMID: 12759801 Clinical Trial.
-
Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users: the longitudinal perspective.J Psychopharmacol. 2006 Mar;20(2):211-25. doi: 10.1177/0269881106059486. J Psychopharmacol. 2006. PMID: 16510479 Review.
-
Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users.Psychopharmacology (Berl). 2003 Apr;167(1):85-96. doi: 10.1007/s00213-002-1383-9. Epub 2003 Mar 11. Psychopharmacology (Berl). 2003. PMID: 12632248
-
Long-term neuropsychological effects of ecstasy in middle-aged ecstasy/polydrug users.Psychopharmacology (Berl). 2010 Jan;207(4):583-91. doi: 10.1007/s00213-009-1688-z. Epub 2009 Oct 13. Psychopharmacology (Berl). 2010. PMID: 19823808
-
MDMA in humans: factors which affect the neuropsychobiological profiles of recreational ecstasy users, the integrative role of bioenergetic stress.J Psychopharmacol. 2006 Mar;20(2):147-63. doi: 10.1177/0269881106063268. J Psychopharmacol. 2006. PMID: 16510474 Review.
Cited by
-
Sex-based changes in rat brain serotonin and behavior in a model of altitude-related vulnerability to treatment-resistant depression.Psychopharmacology (Berl). 2021 Oct;238(10):2867-2881. doi: 10.1007/s00213-021-05902-y. Epub 2021 Jun 22. Psychopharmacology (Berl). 2021. PMID: 34159421
-
Sex Differences in Tryptophan Metabolism: A Systematic Review Focused on Neuropsychiatric Disorders.Int J Mol Sci. 2023 Mar 22;24(6):6010. doi: 10.3390/ijms24066010. Int J Mol Sci. 2023. PMID: 36983084 Free PMC article.
-
The Association between Baseline Subjective Anxiety Rating and Changes in Cardiac Autonomic Nervous Activity in Response to Tryptophan Depletion in Healthy Volunteers.Medicine (Baltimore). 2016 May;95(19):e3498. doi: 10.1097/MD.0000000000003498. Medicine (Baltimore). 2016. PMID: 27175645 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical